Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | polyketide synthase | 0.0154 | 0.4093 | 0.554 |
Giardia lamblia | Methyltransferase like 2 | 0.005 | 0 | 0.5 |
Mycobacterium ulcerans | thioesterase | 0.0139 | 0.351 | 0.4742 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0154 | 0.4093 | 0.554 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0165 | 0.4503 | 0.6122 |
Onchocerca volvulus | 0.0291 | 0.9494 | 0.9285 | |
Leishmania major | hypothetical protein, conserved | 0.005 | 0 | 0.5 |
Mycobacterium ulcerans | polyketide synthase | 0.0165 | 0.4503 | 0.61 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0053 | 0.0085 | 0.006 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0165 | 0.4503 | 0.61 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0139 | 0.351 | 0.471 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.012 | 0.2751 | 0.374 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0154 | 0.4093 | 0.5513 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0165 | 0.4503 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0162 | 0.4407 | 0.5991 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0237 | 0.7356 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0154 | 0.4093 | 0.554 |
Loa Loa (eye worm) | hypothetical protein | 0.0268 | 0.8578 | 1 |
Schistosoma mansoni | methyltransferase-related | 0.005 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0053 | 0.0085 | 0.0115 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0108 | 0.2292 | 0.2995 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0165 | 0.4503 | 0.6077 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0154 | 0.4093 | 0.554 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.1193 | 0.0195 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0165 | 0.4503 | 0.6077 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0119 | 0.2708 | 0.4314 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0097 | 0.1859 | 0.2486 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0237 | 0.7356 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0121 | 0.2805 | 0.374 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0165 | 0.4503 | 0.61 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0124 | 0.2891 | 0.3931 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0154 | 0.4093 | 0.5513 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0139 | 0.351 | 0.4771 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0068 | 0.068 | 0.0925 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0121 | 0.2805 | 0.3778 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0301 | 0.9904 | 1 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0156 | 0.4176 | 0.4155 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0162 | 0.4407 | 0.5991 |
Mycobacterium ulcerans | thioesterase TesA | 0.0139 | 0.351 | 0.4742 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0121 | 0.2805 | 0.3778 |
Brugia malayi | AMP-binding enzyme family protein | 0.0051 | 0.0041 | 0.0041 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0095 | 0.1763 | 0.2397 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0097 | 0.1859 | 0.244 |
Loa Loa (eye worm) | fatty acid synthase | 0.0165 | 0.4521 | 0.4614 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0154 | 0.4093 | 0.5565 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0154 | 0.4093 | 0.554 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0154 | 0.4093 | 0.5565 |
Brugia malayi | AMP-binding enzyme family protein | 0.0156 | 0.4176 | 0.4176 |
Trichomonas vaginalis | conserved hypothetical protein | 0.005 | 0 | 0.5 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0165 | 0.4503 | 0.6077 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0156 | 0.4176 | 0.5677 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0237 | 0.7356 | 1 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0154 | 0.4093 | 0.4093 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0097 | 0.1859 | 0.2486 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0237 | 0.7356 | 1 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0165 | 0.4503 | 0.6122 |
Mycobacterium tuberculosis | Polyketide synthetase MbtD (polyketide synthase) | 0.0051 | 0.0041 | 0.0056 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0165 | 0.4503 | 0.6122 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0154 | 0.4093 | 0.5565 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 48 % | Antiproliferative activity against human NCI-H460 cells at 100 uM after 48 hrs | ChEMBL. | 17064918 |
Activity (functional) | = 76 % | Antiproliferative activity against human MCF7 cells at 100 uM after 48 hrs | ChEMBL. | 17064918 |
Activity (functional) | = 76 % | Antiproliferative activity against human SF268 cells at 100 uM after 48 hrs | ChEMBL. | 17064918 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.